T36.2X2
Poisoning by chloramphenicol group, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by chloramphenicol group, classified under ICD-10 code T36.2X2, refers to cases where an individual intentionally harms themselves by ingesting, inhaling, or otherwise exposing themselves to chloramphenicol, an antibiotic. While chloramphenicol is effective against various bacterial infections, misuse or overdose can lead to significant health risks. This condition emphasizes the importance of proper medication use and mental health awareness to prevent self-harm incidents.
Causes & Symptoms
Clinical Causes: Intentional self-harm with the aim of causing harm or distress Misuse of chloramphenicol due to misunderstanding of its risks Psychological issues or mental health disorders leading to deliberate poisoning Attempted suicide or self-injury using chloramphenicol-containing products Lack of awareness about the dangers of overdosing antibiotic medications
Key Symptoms: Gastrointestinal symptoms: nausea, vomiting, diarrhea, abdominal pain Hematological effects: anemia, leukopenia, thrombocytopenia Neurological symptoms: headache, dizziness, confusion Respiratory issues in severe cases: shortness of breath, cyanosis Signs of systemic toxicity: chills, fever, weakness Possible allergic reactions such as rash or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical history and physical examination. Key steps include:
Treatment Protocols: Treatment focuses on managing symptoms, reducing toxin levels, and supporting mental health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T36.2X2 a billable ICD-10 code?
Yes, T36.2X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T36.2X2?
Clinical documentation must specify the nature of Poisoning by chloramphenicol group, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
